Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate
2006-10-03
2006-10-03
Minnifield, Nita (Department: 1645)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
C424S145100, C424S178100, C424S141100, C424S085400, C424S130100, C424S085500, C424S158100, C424S078040, C514S002600, C514S912000, C530S388100, C530S389200, C530S388230, C530S388150, C530S387100
Reexamination Certificate
active
07115263
ABSTRACT:
The present invention comprises and utilizes methods and compositions for treating hyperimmune reactions in the eye. Compositions comprising antibodies to gamma interferon alone and in combination with other drugs are described. Also disclosed in the invention are methods of applying a composition comprising interferon gamma antibodies topically to the eye to treat hyperimmune reactions, such as transplant rejection, uveitis, autoimmune diseases of the eye, and ocular disorders incidental to or connected with autoimmune diseases.
REFERENCES:
patent: 4704362 (1987-11-01), Itakura et al.
patent: 5759808 (1998-06-01), Casterman et al.
patent: 5800988 (1998-09-01), Casterman et al.
patent: 5840526 (1998-11-01), Casterman et al.
patent: 5888511 (1999-03-01), Skurkovich et al.
patent: 6015695 (2000-01-01), Casterman et al.
patent: 6036956 (2000-03-01), Jacob et al.
patent: 6180370 (2001-01-01), Queen et al.
patent: 6534059 (2003-03-01), Skurkovich et al.
patent: 6844315 (2005-01-01), Khan et al.
patent: 6861056 (2005-03-01), Skurkovich et al.
patent: 2002/0182212 (2002-12-01), Skurkovich et al.
patent: 2003/0215448 (2003-11-01), Skurkovich et al.
patent: 2003/0224005 (2003-12-01), Skurkovich et al.
patent: 2004/0022869 (2004-02-01), Chen et al.
patent: 2004/0136988 (2004-07-01), Skurkovich et al.
patent: 2004/0224876 (2004-11-01), Jost-Price et al.
patent: 2004/0265321 (2004-12-01), Johnson et al.
patent: 2005/0152902 (2005-07-01), Skurkovich et al.
patent: 2005/0175613 (2005-08-01), Skurkovich et al.
patent: WO 87/02671 (1987-05-01), None
Tarrant et al, J. Exp. Med., 1999, 189/2:219-230.
Egwuagu et al, J. Immunol., 1999, 162:510-517.
Tarrant et al, J. Immunol., 1998, 161:122-127.
Silver et al, J. Immunol., 2000, 165:5041-5047.
Hooks et al, J. Neuroimmunol., 1990, 26/3:245-250 Abstract only.
Dekaris et al, Croat. Med. J., 2001, 42/6:650-656 Abstract only.
Yang et al, Br. J. Ophthalmol., 1998, 82/6:695-699 Abstract only.
Singh et al, Immunol. Res., 2001, 23/1:59-74.
Kotter et al, clinical and Experimental Rheumatology, 1996, 14:313-315.
Lacomba et al, Arch. Ophthalmol., 2000, 118:768-772.
Atalla et al, Elsevier Science Publishers (Biomedical Division), Ocular Immunology Today, eds. Usui et al, 1990, pp. 65-68.
Kijlstra, Eye, 1997, 11/Pt. 2:200-205.
Hu et al, Cell Research, 2001, 11/4:293-300 Abstract only.
Wu et al, J. Neuroimmunol., 2003, 137/1-2:154-163 Abstract only.
Hooks et al, Invest. Ophthalmol. Vis. Sci., 1988, 29:1444-1451.
de Kozak et al, Intern. Rev. Immunol., 2002, 21:231-253.
Nguyen et al, Molecular Immunology, 1999, 36:515-524.
Avunduk et al, am. J. Ophthalmol. 2003, 136:593-602.
Teng et al, Blood Cells, Molecules, and Diseases, Jun. 2000, 26/3:177-185 (abstarct only).
Krause et al, Am. J. Med., 2003, 115:390-397.
Cogne et al, Res. Immunol. 1989, 140:487-502.
Wahner-Roedler et al, Medicine, 2003, 82/4:236-250.
Skurkovich et al, Curr. Opin. Mol. Ther., 2003, 5/1:52-57 Abstract only.
Kotter et al, Semin. Arthritis Rheum., 2004, 33:320-335.
Fuji et al, J. Immunology, Apr. 1983, 130/4:1683-1686.
Wahner-Roedler et al, Medicine, 2003, 82:236-250.
Becker et al, Current Opinion in Ophthalmology, Dec. 2000, 11/6:472-477 Abstract only.
Bird et al., 1988, Science 242: 423-426 (1988).
Feldman et al., “Interferons and Autoimmunity”, IFN γ, p. 75, Acadmeic Press (1987).
Gillam and Smith, Gene 8: 81-97 (1979).
Gringeri et al., Cell. Mol. Biol. 41 (3): 381-387 (1995).
Gringeri et al., J. Acquir. Immun. Defic. Syndr. 13:55-67 (1996).
Gu et al., Thrombosis and Hematocyst, 77 (4):755-759 (1997).
Hamers-Casterman et al., Nature 363: 446-448 (1993).
Huston et al., Proc. Natl. Acad. Sci. USA 85: 5879-5883 (1988).
Queen et al., Immunol. Rev. 89: 49-68 (1986).
Roberts et al., Nature 328: 731-734 (1979).
Sastry et al., Proc. Natl'l Acad. Sci. USA, 86: 5728 (1989).
Seligmann et al., Immunological Rev. 48: 145-167 (1979).
Skurkovich et al., Annals of Allergy, 35: 356 (1975).
Skurkovich et al., J. Interferon Res. 12, Suppl. 1:S110 (1992).
Skurkovich et al., Med. Hypoth., 41: 177-185 (1993).
Skurkovich et al., Med. Hypoth., 42: 27-35 (1994).
Skurkovich et al., Nature 217: 551-552 (1974).
Tuszynski et al., Blood, 72:109-115 (1988).
Ward et al., Nature 341: 544-546 (1989).
Skurkovich Boris
Skurkovich Simon
Advanced Biotherapy, Inc.
Drinker Biddle & Reath LLP
Minnifield Nita
LandOfFree
Compositions and methods for treating hyperimmune response... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for treating hyperimmune response..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treating hyperimmune response... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3709188